Crossref
Antiphospholipid syndrome: Classification versus diagnosis
Medicina Clínica · 2024-08 · 163 · S10-S13
DOI: 10.1016/j.medcli.2024.04.005 ↗Kurz gefasst
Fachartikel in der Zeitschrift Medicina Clínica, 2024-08. Verfasst von Doruk Erkan. Beteiligte Einrichtung: Barbara Volcker Center for Women and Rheumatic Diseases, Hospital for Special Surgery, Weill Cornell Medicine, New York, NY, USA. Electronic address:…. Hauptthemen laut MEDLINE: Antiphospholipid Syndrome. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 11 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Antiphospholipid SyndromeHumansAntibodies, Antiphospholipid
Substanzen
Antibodies, Antiphospholipid
Autor:innen und Institutionen
- Barbara Volcker Center for Women and Rheumatic Diseases, Hospital for Special Surgery, Weill Cornell Medicine, New York, NY, USA. Electronic address: erkand@hss.edu.
Zitieren
APA
Erkan, D. (2024). Antiphospholipid syndrome: Classification versus diagnosis. Medicina Clínica, 163, S10-S13. https://doi.org/10.1016/j.medcli.2024.04.005
Vancouver
Erkan D. Antiphospholipid syndrome: Classification versus diagnosis. Medicina Clínica. 2024;163:S10-S13. doi:10.1016/j.medcli.2024.04.005
BibTeX
@article{Erkan2024,
author = {Erkan, Doruk},
title = {Antiphospholipid syndrome: Classification versus diagnosis},
journal = {Medicina Clínica},
year = {2024},
volume = {163},
pages = {S10--S13},
doi = {10.1016/j.medcli.2024.04.005}
}
EUVIMED